Data as of 1:17pm ET
 -0.02 / -1.16%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

GenVec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. It is working with other companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. The company's development programs address therapeutic areas such as hearing loss, balance disorders and cancer; as well as vaccines against infectious diseases, including respiratory syncytial virus, herpes simplex virus, dengue fever and malaria. GenVec was founded in December 1992 and is headquartered in Gaithersburg, MD.

Contact Information

GenVec, Inc.
65 West Watkins Mill Road
Gaithersburg Maryland 20878
P:(240) 632-0740
Investor Relations:
(240) 632-5501



Other institutional37.41%
Individual stakeholders20.48%
Mutual fund holders1.30%

Top Executives

Douglas J. SwirskyPresident, CEO, CFO, Secretary, Treasurer & SVP
Douglas E. BroughChief Scientific Officer
Bryan T. ButmanSenior Vice President-Development
Rena CohenHead-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.